Investor Relations
Advanced Longevity & Wellness, backed by forty years of regenerative science.
Lionheart Longevity is the clinical face of a forty-year regenerative-medicine platform: patented bioelectric protocols, physician-led diagnostics, and hybrid in-clinic and at-home delivery.
- Years of regenerative medicine execution
- 40+
- Patent claims across bioelectric platforms
- 800+
- Physicians on the clinical & scientific advisory board
- 60+
Rule 506(c) Private Offering
$3 Million Capital Raise
Lionheart Health, Inc. has filed a Form D for a private placement of up to $3 million under Rule 506(c) of Regulation D. Participation is limited to accredited investors, whose status must be verified before they invest.
Please review the Private Placement Memorandum, including its risk factors, before investing. Regulatory documents and other due diligence materials are in the company documents library.
This website is not an offer to sell or a solicitation of an offer to buy securities. Any offer is made only through the Private Placement Memorandum, to verified accredited investors. Investing involves risk, including possible loss of principal.
Video
Lionheart Health Overview
Investor Contact
Investor Relations
Attn: Shareholder RelationsLionheart Health, Inc.21060 Pacific City Cir, #6115Huntington Beach, CA 92648Shareholder Resources
Questions for our investor relations team?